Page last updated: 2024-11-04

temazepam and Pheochromocytoma

temazepam has been researched along with Pheochromocytoma in 1 studies

Temazepam: A benzodiazepine that acts as a GAMMA-AMINOBUTYRIC ACID modulator and anti-anxiety agent.

Pheochromocytoma: A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kujubu, DA1
Lim, RW1
Varnum, BC1
Herschman, HR1

Other Studies

1 other study available for temazepam and Pheochromocytoma

ArticleYear
Induction of transiently expressed genes in PC-12 pheochromocytoma cells.
    Oncogene, 1987, Volume: 1, Issue:3

    Topics: Animals; Benzodiazepines; Cell Differentiation; Cell Division; Cell Line; Cycloheximide; Dexamethaso

1987